Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P Futures
5,895.00
-1.25(-0.02%)
Dow Futures
43,148.00
-29.00(-0.07%)
Nasdaq Futures
20,511.25
-8.25(-0.04%)
Russell 2000 Futures
2,251.50
-4.00(-0.18%)
Crude Oil
70.54
-0.02(-0.03%)
Gold
2,736.00
-2.90(-0.11%)

Compass Therapeutics, Inc. (CMPX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

1.8500

-0.0100

(-0.54%)

At close: 04:00PM EDT

1.8500

0.00

(0.00%)

After hours:

07:08PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	255.92M
Enterprise Value	110.78M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	289.52
Price/Book (mrq)	1.75
Enterprise Value/Revenue	130.33
Enterprise Value/EBITDA	-8.92

Trading Information

Stock Price History

Beta (5Y Monthly)	0.73
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	2.3400
52 Week Low ³	0.7650
50-Day Moving Average ³	1.5726
200-Day Moving Average ³	1.5026

Share Statistics

Avg Vol (3 month) ³	463.12k
Avg Vol (10 day) ³	568.33k
Shares Outstanding ⁵	137.59M
Implied Shares Outstanding ⁶	N/A
Float ⁸	88.57M
% Held by Insiders ¹	12.04%
% Held by Institutions ¹	72.08%
Shares Short (Sep 30, 2024) ⁴	2.49M
Short Ratio (Sep 30, 2024) ⁴	5.14
Short % of Float (Sep 30, 2024) ⁴	2.56%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	1.81%
Shares Short (prior month Aug 30, 2024) ⁴	1.86M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-1,770.00%

Management Effectiveness

Return on Assets (ttm)	-20.58%
Return on Equity (ttm)	-30.05%

Income Statement

Revenue (ttm)	850k
Revenue Per Share (ttm)	0.01
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-54.5M
Net Income Avi to Common (ttm)	-47.24M
Diluted EPS (ttm)	-0.3500
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	146.23M
Total Cash Per Share (mrq)	1.06
Total Debt (mrq)	1.09M
Total Debt/Equity (mrq)	0.75
Current Ratio (mrq)	16.15
Book Value Per Share (mrq)	1.06

Cash Flow Statement

Operating Cash Flow (ttm)	-42.92M
Levered Free Cash Flow (ttm)	-23.76M